Seminars in Oncology
Volume 33, Issue 2 , Pages 230-239 , April 2006

Autoimmune Complications of Chronic Lymphocytic Leukemia

  • Terry J. Hamblin

      Affiliations

    • Corresponding Author InformationAddress correspondence to Dr Terry J,. Hamblin, 15 Queens Park S Dr, Bournemouth BH8 9BQ, UK

References 

  1. Engelfriet CP , Overbeeke MAM , von dem Borne AEGK . Autoimmune hemolytic anaemia . Semin Hematol . 1992;29:3–12
  2. Berlin R . Red cell survival studies in normal and leukaemic subjects; latent haemolytic syndrome in leukaemia with splenomegaly—Nature of anaemia in leukaemia–Effect of splenomegaly . Acta Med Scand . 1951;139(suppl 252):1–141
  3. Wasserman LR , Stats D , Schwartz L , et al.   Symptomatic and hemopathic hemolytic anaemia . Am J Med . 1955;18:961–989
  4. Pisciotta AV , Hirschboeck JS . Therapeutic considerations in chronic lymphocytic leukemia . Arch Intern Med . 1957;99:334–335
  5. Beickert A . Die hämolytische Verlausform der chronischen lymphatischen Leukämie . Munch Med Woschenschr . 1959;101:2067–2072
  6. Dameshek W , Schwartz RS . Leukemia and auto-immunization. Some possible relationships . Blood . 1959;14:1151–1158
  7. Troup SB , Swisher SN , Young LE . The anemia of leukemia . Am J Med . 1960;28:751–763
  8. Videbæk AA . Auto-immune hemolytic anemia in some malignant systemic diseases . Acta Med Scand . 1962;171:463–476
  9. Bergsagel DE . The chronic leukaemias (A review of disease manifestations and the aims of therapy) . Can Med Assoc J . 1967;96:1615–1620
  10. Dighiero G . Hypogammaglobulinemia and disordered immunity in CLL . In:  Cheson B editors. Chronic Lymphocytic Leukaemia (Scientific Advances and Clinical Developments) . New York: NT, Dekker; 1993;p. 167–180
  11. Hamblin TJ , Oscier DG , Young BJ . Autoimmunity in chronic lymphocytic leukaemia . J Clin Pathol . 1986;39:713–716
  12. Minot GR , Buckman TE . The blood platelets in the leukemias . Am J Med Sci . 1925;169:477–485
  13. Harrington WJ , Arimura G . Immune reactions of platelets . In:  Johnson SA ,  Monto RW ,  Rebuck JW , et al. editor. Blood Platelets . Boston, MA: Little Brown; 1961;p. 659–670
  14. Ebbe S , Wittels B , Dameshek W . Autoimmune thrombocytopenic purpura (“ITP type”) with chronic lymphocytic leukemia . Blood . 1962;19:23–27
  15. Dührsen U , Augener W , Zwingers T , et al.   Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders (Analysis of 637 cases and comparison with myeloproliferative diseases) . Br J Haematol . 1987;67:235–239
  16. Loughran TP , Kardin ME , Starkebaum G , et al.   Leukaemia of large granular lymphocytes (association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anaemia) . Ann Intern Med . 1986;102:169–175
  17. Katrinakis G , Kyriakou D , Alexandrakis M , et al.   Evidence for involvement of activated CD8+/HLA-DR+ cells in the pathogenesis of neutropenia in patients with B-cell chronic lymphocytic leukaemia . Eur J Haematol . 1995;55:33–41
  18. Lamy T , Loughran TP . Current concepts (Large granular lymphocyte leukaemia) . Blood Rev . 1999;13:230–240
  19. Lacy MQ , Kurtin PJ , Tefferi A . Pure red cell aplasia (Association with large granular lymphocytic leukaemia and the prognostic value of cytogenetic abnormalities) . Blood . 1996;87:3000–3006
  20. Chikkappa G , Zarrabi MH , Tsan MF . Pure red cell aplasia in patients with chronic lymphocytic leukaemia . Medicine (Baltimore) . 1986;65:339–351
  21. Diehl LF , Ketchum LH . Autoimmune disease and chronic lymphocytic leukaemia (Autoimmune hemolytic anaemia, pure red cell aplasia and autoimmune thrombocytopenia) . Semin Hematol . 1998;25:80–97
  22. Lehner-Netsch G , Barry A , Delage JM . Leukemias and autoimmune diseases (Sjøgren’s syndrome and hemolytic anemia associated with chronic lymphocytic anemia) . Can Med Assoc J . 1969;100:1151–1154
  23. Dathan JRE , Heyworth MF , MacIver AG . Nephtotic syndrome in chronic lymphocytic leukaemia . Br Med J . 1974;3:655–657
  24. Cuni LJ , Grünwald H , Rosner F . Bullous pemphigoid in chronic lymphocytic leukemia with the demonstration of anti-basement membrane antibodies . Am J Med . 1974;57:987–992
  25. Haubenstock A , Zalusky R . Autoimmune hyperthyroidism and thrombocytopenia in a patient with chronic lymphocytic leukemia . Am J Hematol . 1985;19:281–283
  26. Miller DG . Patterns of immunological deficiency in lymphomas and leukemias . Ann Intern Med . 1962;57:703–715
  27. Dameshek W . Chronic lymphocytic leukemia—An accumulative disease of immunologically incompetent lymphocytes . Blood . 1967;24:566–584
  28. Sokol RJ , Hewitt S , Booker DJ , et al.   An enzyme-linked direct antiglobulin test for assessing erythrocyte bound immunoglobulins . J Immunol Methods . 1988;106:31–35
  29. Mauro FR , Foa R , Cerretti R , et al.   Autoimmune hemolytic anemia in chronic lymphocytic leukemia (Clinical, therapeutic, and prognostic features) . Blood . 2000;95:2786–2792
  30. Stevenson FK , Hamblin TJ , Stevenson GT , et al.   Extracellular idiotypic immunoglobulin arising from human leukaemia B lymphocytes . J Exp Med . 1980;152:1484–1496
  31. Broker BM , Klajman A , Youinou P , et al.   Chronic lymphocytic leukemis (CLL) cells secrete multispecific autoantibodies . J Autoimmune . 1988;1:469–481
  32. Sthoeger ZM , Wakai M , Tse DB , et al.   Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia . J Exp Med . 1989;169:255–268
  33. Beaume A , Brizard A , Dreyfus B , et al.   High incidence of serum monoclonal Igs detected by a sensitive immunoblotting technique in B-cell chronic lymphocytic leukemia . Blood . 1994;84:1216–1219
  34. Manohar V , Brown E , Leiserson WM , et al.   Expression of Ly-1 by a subset of B lymphocytes . J Immunol . 1982;129:532–538
  35. Hayakawa K , Hardy RR , Parks DR , et al.   The Ly-1 B cell subpopulation in normal, immunodefective and autoimmune mice . J Exp Med . 1983;157:202–218
  36. Herzenberg LA , Stall AM , Lalor PA , et al.   The Ly1-B cell lineage . Immunol Rev . 1986;93:81–102
  37. Hayakawa K , Hardy RR , Herzenberg LA . Peritoneal Ly1-B cells (Genetic control, autoantibody production, increased lambda light chain expression) . Euro J Immunol . 1986;16:450–456
  38. Dighiero G . Relevance of murine models in elucidating the origin of B-CLL lymphocytes and related immune associated phenomena . Semin Hematol . 1987;24:240–251
  39. Dighiero G , Poncet P , Rouyre S , et al.   Newborn Xid mice carry the genetic information for the production of natural autoantibodies . J Immunol . 1986;136:4000–4005
  40. Miller RA , Gralow J . The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbolmyristic acetate (PMA) . J Immunol . 1984;133:3408–3412
  41. Holmberg D , Forsgren S , Ivars F , et al.   Reactions among IgM antibodies derived from normal neonatal mice . Eur J Immunol . 1984;14:435–440
  42. Lymberi P , Dighiero G , Ternyck T , et al.   A high incidence of cross reactive idiotypes among murine natural autoantibodies . Eur J Immunol . 1985;5:702–707
  43. Kearney JF , Vakil M . Idiotype directed interactions during ontogeny play a major role in the establishment of the adult B cell repertoire . Immunol Rev . 1986;94:39–62
  44. Dighiero G , Hart S , Lim A , et al.   Autoantibody activity of immunoglobulins isolated from B cell follicular lymphomas . Blood . 1981;78:581–585
  45. Sikora K , Kirkorian J , Levy R . Monoclonal immunoglobulin rescued from a patient with chronic lymphocytic leukemia and AIHA . Blood . 1979;54:513–518
  46. Sthoeger ZM , Stoeger D , Shtalrid M , et al.   Mechanism of AIHA in chronic lymphocytic leukemia . Am J Hematol . 1993;43:259–264
  47. Pascual V , Victor K , Lelsz D , et al.   Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype . J Immunol . 1991;146:4385–4391
  48. Pascual V , Victor K , Spellerberg M , et al.   VH restriction among human cold agglutinins (The VH4-21 gene segment is required to encode anti-I and anti-i specificities) . J Immunol . 1992;149:2337–2344
  49. Crisp D , Pruzanski W . B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins) . Am J Med . 1982;72:915–922
  50. Ruzickova S , Pruss A , Odendahl M , et al.   Chronic lymphocytic leukemia preceded by cold agglutinin disease (Intraclonal immunoglobulin light chain diversity in V(H)4-34 expressing single leukemic cells) . Blood . 2002;100:3419–3422
  51. Zaja F , Vianelli N , Sperotto A , et al.   Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases . Leuk Lymphoma . 2003;44:1951–1955
  52. He S , Tsang S , North J , et al.   Epitope mapping of C1 inhibitor autoantibodies from patients with acquired C1 inhibitor deficiency . J Immunol . 1996;156:2009–2013
  53. Chevailler A , Arlaud G , Ponard D , et al.   C-1-inhibitor binding monoclonal immunoglobulins in three patients with acquired angioneurotic edema . J Allergy Clin Immunol . 1996;97:998–1008
  54. Lewis FB , Schwarz RS , Damashek W . X-irradiation and alkylating agents as possible trigger mechanisms in autoimmune complications of malignant lymphoproliferative diseases . Clin Exp Immunol . 1966;1:3–11
  55. Catovsky D , Foa R . B-cell chronic lymphocytic leukaemia . In:  Catovsky D ,  Foa R editor. The Lymphoid Leukaemias . London, UK: Butterworths; 1990;p. 73–112
  56. Thompson-Moya L , Martin T , Heuft HG , et al.   Allergic reaction with immune hemolytic anaemia arising from chlorambucil . Am J Hematol . 1989;32:230–231
  57. Hansen MM . Chronic lymphocytic leukaemia (Clinical studies based on 189 cases followed for a long time) . Scand J Haematol . 1973;18(suppl 1):1–282
  58. Myint H , Copplestone JA , Orchard J , et al.   Fludarabine-related AIHA in patients with chronic lymphocytic leukaemia . Br J Haematol . 1995;91:341–344
  59. Bastion Y , Coiffier B , Dumontet C , et al.   Severe AIHA in two patients treated with fludarabine for chronic lymphocytic leukemia . Ann Oncol . 1992;3:171–172
  60. Di Raimondo F , Guistolisi R , Cacciola E , et al.   AIHA in chronic lymphocytic leukemia patients treated with fludarabine . Leuk Lymphoma . 1993;11:63–68
  61. Weiss RB , Freiman J , Kweder SL , et al.   Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia . J Clin Oncol . 1998;16:1885–1889
  62. Hamblin TJ . Autoimmune disease and its management in chronic lymphocytic leukaemia . In:  Cheson BD editors. Chronic Lymphoid Leukemias (ed 2) . New York, NY: Dekker; 2001;p. 435–458
  63. Montillo M , Tedeschi A , Leoni P . Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukaemia . Leuk Lymphoma . 1994;15:187–188
  64. Stern SC , Shah S , Costello C . Probable autoimmune neutropenia induced by fludarabine treatment for chronic lymphocytic leukaemia . Br J Haematol . 1999;106:836–837
  65. Antich Rojas J , Balaguer H , Cladera A . Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukaemia . Sangre (Barcelona) . 1997;42:254–256
  66. Leporier M , Reman O , Troussard X . Pure red cell aplasia with fludarabine for chronic lymphocytic leukaemia . Lancet . 1993;342:555
  67. Byrd JC , Hertler AA , Weiss RB , et al.   Fatal recurrence of autoimmune hemolytic anaemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anaemia . Ann Oncol . 1995;6:300–301
  68. Robak T , Blasinska-Morawiec M , Krykowski E , et al.   Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine) . Eur J Haematol . 1997;58:109–113
  69. Hamblin TJ , Orchard JA , Myint H , et al.   Fludarabine and hemolytic anaemia in chronic lymphocytic leukaemia . J Clin Oncol . 1998;16:3209
  70. Fleischman RA , Croy D . Acute onset of severe autoimmune hemolytic anaemia after treatment with 2-chlorodeoxyadenosine for chronic lymphocytic leukaemia . Am J Hematol . 1995;48:293
  71. Chasty RC , Myint H , Oscier DG , et al.   Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA) . Leukemia Lymphoma . 1998;29:391–398
  72. Otton SH , Turner DL , Frewin R , et al.   Autoimmune thrombocytopenia after treatment with Campath 1H in a patient with chronic lymphocytic leukaemia . Br J Haematol . 1999;106:261–262
  73. Orchard J , Bolam S , Myint H , et al.   In patients with lymphoid tumours recovering from the autoimmune complications of fludarabine, relapse may be triggered by conventional chemotherapy . Br J Haematol . 1998;102:1112–1113
  74. Eichhorst BF , Busch R , Hopfinger G , et al.   Fludarabine plus cyclophosphamide (FC) is superior to fludarabine (F) alone in first line therapy of chronic lymphocytic leukemia (CLL) (Results of a phase III study of the German CLL study group (GCLLSG) Haematologica) . 2005;90:144; suppl, abstr 0366
  75. Catovsky D , Richards S , Hillman P . Early results from LRF CLL4 (A UK multicenter randomized trial) . Blood . 2005;106:212a; suppl, abstr
  76. Bazarbachi A , Bachelez H , Dehen L , et al.   Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine . Ann Oncol . 1995;6:730–731
  77. Braess J , Reich K , Willert S , et al.   Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin’s lymphoma of B-cell type (B-NHL) . Ann Hematol . 1997;75:227–230
  78. Gooplu C , Littlewood TJ , Frith P , et al.   Paraneoplastic pemphigus—An association with fludarabine . Br J Dermatol . 2001;144:1102–1104
  79. Oppenheim M . Verhandlungen Der Weiner Dermatologischen Gesellschaft . Arch Dermatol Syphiligr . 1910;101:379–382
  80. Sachs O . Ueber Pemphigoide Hauteruption in Einem Falle von Lymphatischer Leukaemie . Wien Klin Wochenschr . 1921;34:317
  81. Laskaris GC , Papavasilou SS , Bovopoulou OD , et al.   Association of oral pemphigus with chronic lymphocytic leukemia . Oral Surg Oral Med Oral Pathol . 1980;50:244–249
  82. Goodnough LT , Muir A . Bullous pemphigoid as a manifestation of chronic lymphocytic leukaemia . Arch Intern Med . 1980;140:1526–1527
  83. Anhalt GJ , Kim SC , Stanley JR , et al.  Paraneoplastic pemphigus   An autoimmune mucocutaneous disease associated with neoplasia . N Engl J Med . 1990;323:1729–1735
  84. Fried R , Lynfield Y , Vitale P , et al.   Paraneoplastic pemphigus appearing as a bullous pemphigoid eruption after palliative radiation therapy . J Am Acad Dermatol . 1993;29:815–817
  85. Lee MS , Kossard S , Ho KK , et al.   Paraneoplastic pemphigus triggered by radiotherapy . Aust J Dermatol . 1995;36:206–210
  86. Macheta MP , Parapia LA , Gouldesbrough DR . Renal failure in a patient with chronic lymphocytic leukaemia treated with fludarabine . J Clin Pathol . 1995;48:181–182
  87. Tisler A , Pierratos A , Lipton JH . Crescentic glomerulonephritis with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia . Nephrol Dial Transplant . 1996;11:2306–2308
  88. Boldt DH , Van Hoff DD , Kuhn JG , et al.   Effect on human peripheral lymphocytes of the in vivo administration of 9-β-D-arabinofuranosyl-5′-monophosphate (NSC312887) a new purine antimetabolite . Cancer Res . 1984;44:4661–4666
  89. Rosenkrantz K , Dupont B , Flomenberg N . Relevance of autocytotoxic and autoregulatory lymphocytes in the maintenance of self tolerance . Concepts Immunopathol . 1987;4:22–41
  90. Shevach EM , Thornton A , Suri-Payer E . T lymphocyte-mediated control of autoimmunity . Novartis Found Symp . 1998;215:200–211
  91. Takahashi T , Kuniyasu Y , Toda M , et al.   Immunologic self-tolerance maintained by CD25+ CD4+ naturally anergic and suppressive T cells (Induction of autoimmune disease by breaking their anergic/suppressive state) . Int Immunol . 1998;19:1969–1980
  92. Thornton AM , Shevach EM . CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation by inhibiting interleukin 2 production . J Exp Med . 1998;188:287–296
  93. Winberg K , Parkman R . Age, the thymus and T lymphocytes . N Engl J Med . 1995;332:182–183
  94. Peller S , Kaufman S . Decreased CD45RA T cells in B-cell chronic lymphatic leukaemia patients (Correlation with disease stage) . Blood . 1991;78:1569–1573
  95. Serreze DV , Fleming SA , Chapman HD , et al.   B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice . J Immunol . 1998;161:3912–3918
  96. Dazzi F , D’Andrea E , Biasi G , et al.   Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens . Clin Immunol Immunopathol . 1995;75:26–32
  97. Barker RN , Hall AM , Standen GR , et al.   Identification of T-cell epitopes on the Rhesus polypeptides in autoimmune hemolytic anemia . Blood . 1997;90:62701–62715
  98. Hall AM , Vickers MA , McLeod E , et al.   Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells . Blood . 2005;105:2007–2015
  99. Barcellini W , Montesano R , Clerici G , et al.   In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia . Am J Hematol . 2002;71:177–183
  100. Efremov DG , Ivanovski M , Siljanovski N , et al.   Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia . Blood . 1996;87:3869–3876
  101. Hamblin T , Davies Z , Oscier D , et al.   In chronic lymphocytic leukaemia (CLL) autoimmune haemolytic anaemia (AIHA) is not related to any particular immunoglobulin V gene usage . Br J Haematol . 1999;105(suppl 1):88
  102. Bessudo A , Chen A , Rassenti LZ , et al.   Autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia apparently is not associated with leukemia cell expression of Ig VH 1-69 (51p1) genes . Blood . 1997;90:209b; suppl 1, abstr 3672
  103. Tobin G , Thunberg U , Karlsson K , et al.   Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia . Blood . 2004;104:2879–2885
  104. Ghiotto F , Fais F , Valetto A , et al.   Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia . J Clin Invest . 2004;113:1008–1016
  105. Messmer BT , Albesiano E , Efremov DG , et al.   Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia . J Exp Med . 2004;200:519–525
  106. Lehman PV , Forsthuber T , Miller A , et al.   Spreading of T cell autoimmunity to cryptic determinants of an autoantigen . Nature . 1992;358:155–157
  107. Hall AM , Ward FJ , Vickers MA , et al.   Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen . Blood . 2002;100:4529–4536
  108. Dameshek W , Komninos ZP . The present status of treatment of autoimmune hemolytic anemia with ACTH and cortisone . Blood . 1956;11:648–664
  109. Collins PW , Newland AC . Treatment modalities of autoimmune blood disorders . Semin Hematol . 1992;29:64–74
  110. Byrd JC , Hertler AA , Weiss RB , et al.   Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia . Ann Oncol . 1995;6:300–301
  111. Hamblin TJ , Orchard JA , Myint H , et al.   Fludarabine and hemolytic anemia in chronic lumphocytic leukemia . J Clin Oncol . 1998;16:3209–3210
  112. Coon WW . Splenectomy in the treatment of hemolytic anemia . Arch Surg . 1985;120:625–6281
  113. Dacie JV . Autoimmune hemolytic anemia . Arch Intern Med . 1975;135:1293–1300
  114. Ruchlemer R , Wotherspoon AC , et al.   Splenectomy in mantle cell lymphoma with leukaemia (A comparison with chronic lymphocytic leukaemia) . Br J Haematol . 2002;118:952–958
  115. Hill J , Walsh RM , McHam S , et al.   Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia (A case series and review of the literature) . Am J Hematol . 2004;75:134–138
  116. Jurlander J , de Nully Brown P , Skov PS , et al.   Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia . Leukemia . 1995;9:1902–1909
  117. Flores G , Cunningham-Rundles C , Newland AC , et al.   Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia (results in 73 patients) . Am J Hematol . 1993;44:237–242
  118. Ruess-Borst MA , Waller HD , Muller CA . Successful treatemnt of steroid resistant hemolysis in chronic lymphocytic leukemia with cyclosporine A . Am J Hematol . 1994;9:357–359
  119. Cortes J , O’Brien S , Loscertales J , et al.   Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia . Cancer . 2001;92:2016–2022
  120. Seipelt G , Bohme A , Koschmieder S , et al.   Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome . Ann Hematol . 2001;80:170–173
  121. Cabrera J , Peñalver FJ , Millan I , et al.   Mabthera (Rituximab) in the treatment of 92 patients with refractory immune thrombocytopenic purpura . Blood . 2004;104:571a; abstr 2074
  122. Tokunaga M , Fujii K , Saito K , et al.   Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab . Rheumatology . 2005;44:176–182
  123. Stasi R , Brunetti M , Stipa E , et al.   Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia . Blood . 2004;103:4424–4428
  124. Dupuy A , Viguier M , Bedane C , et al.   Treatment of refractory pemphigus vulgaris with rituximab (anti-cd20 monoclonal antibody) . Arch Dermatol . 2004;140:91–96
  125. Shaw T , Quan J , Totoritis MC . B cell therapy for rheumatoid arthritis (The rituximab (anti-CD20) experience) . Ann Rheum Dis . 2003;62:55–59
  126. Sansonno D , De Re V , Lauletta G , et al.   Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20 . Blood . 2003;101:3818–3826
  127. Fischer K-G , Deschler B , Lubbert M , et al.   Acquired high-titer factor VIII inhibitor (fatal bleeding despite multimodal treatment including rituximab preceded by multiple plasmapheresis) . Blood . 2003;101:3753–3754
  128. Pestronk A , Florence J , Miller T , et al.   Treatment of IgM antibody associated polyneuropathies using rituximab . J Neurol Neurosurg Psychiatry . 2003;74:485–489
  129. Engelhardt M , Jakob A , Ruter B , et al.   Severe cold hemagglutinin disease (CHD) successfully treated with rituximab . Blood . 2002;100:1922–1923
  130. Gupta N , Kavuru S , Patel D , et al.   Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia . Leukemia . 2002;16:2092–2095
  131. Zaja F , Vianelli N , Sperotto A , et al.   Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases . Leuk Lymphoma . 2003;44:1951–1955
  132. Hegde UP , Wilson WH , White T , et al.   Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia . Blood . 2002;100:2260–2262
  133. Ghazal H . Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia . Blood . 2002;99:1092–1094
  134. Chemnitz J , Draube A , Diehl V , et al.   Successful treatment of steroid and cyclophosphamide-resistant hemolysis in chronic lymphocytic leukemia with rituximab . Am J Hematol . 2002;69:232–233
  135. Heizmann M , Itin P , Wernli M , et al.   Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab (Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL) . Am J Hematol . 2001;66:142–144
  136. Guinet MJ , Liew KH , Quong GG , et al.   A study of splenic irradiation in chronic lymphocytic leukemia . Int J Radiat Oncol Biol Phys . 1989;16:225–229
  137. Esa EC , Ray PK , Swami VK , et al.   Specific immunoadsorption of IgG antibody in a patient with chronic lymphocytic leukemia and autoimmune hemolytic anemia . Am J Med . 1981;71:1035–1040
  138. Vesely SK , Perdue JJ , Rizvi MA , et al.   Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy (A systematic review) . Ann Intern Med . 2004;140:112–120
  139. Ahn YS , Harrington WJ , Mylvagnam R , et al.   Slow infusion of vinca alkaloids in the treatment of idiopathic thrombocytopenic purpura . Ann Intern Med . 1984;100:192–196
  140. Pott-Hoeck C , Hiddemann W . Purine analogues in the treatment of low grade lymphomas and chronic lymphocytic leukemias . Ann Hematol . 1995;6:421–433
  141. Meir F , Sonnichsen K , Schaumburg-Lever G , et al.   Epidermolysis bullosa acquisita (Efficiency of high dose intravenous immunoglobulins) . J Am Acad Dermatol . 1993;29:334–337
  142. Mohr C , Sunderkottewr C , Hildebrand A , et al.   Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins . Br J Dermatol . 1995;132:824–826
  143. Marcovic SN , Inwards DJ , Frigas EA , et al.   Acquired C1 esterase inhibitor deficiency . Ann Intern Med . 2000;132:144–150
  144. Keating MJ , O’Brien S , Albitar M , et al.   Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia . J Clin Oncol . 2005;23:4079–4088

PII: S0093-7754(06)00020-0

doi: 10.1053/j.seminoncol.2006.01.011

Seminars in Oncology
Volume 33, Issue 2 , Pages 230-239 , April 2006

Article Tools